학술논문
A Phase 2, International, Multicenter, Open-label Clinical Trial of Subcutaneous Tbo-Filgrastim in Pediatric Patients With Solid Tumors Undergoing Myelosuppressive Chemotherapy
Document Type
Article
Author
Source
In: Journal of Pediatric Hematology/Oncology . (Journal of Pediatric Hematology/Oncology, 1 October 2019, 41(7):525-531)
Subject
Language
English
ISSN
15363678
10774114
10774114